Health
Guillain-Barré syndrome: Why experts are still “confident” in J&J – Inverse
The chances of developing Guillain-Barré Syndrome (GBS) the Johnson & Johnson Covid-19 vaccine are small; what you need to know…
When news broke early this week that there was a possible association
between the Johnson & JohnsonCovid-19 vaccine and rare neurological disorder, people were understandably alarmed. Around 12.5 million people in the United States have received the one-dose…
Continue Reading
-
Business16 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025
-
Noosa News13 hours agoMeasles alert: Australia Zoo, Hospital ED, Sushi Hub, Holey Moley Mini Golf and train stations among QLD infection sites
-
Business17 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business13 hours ago1 ASX dividend stock down 43% I’d buy right now